Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Somatic Mutation Screen of Clear Cell RCC II

ABSTRACT: Systematic somatic mutation screening of 4000 genes in human clear cell renal cell carcinoma. Information on corresponding somatic mutations in each sample can be found at http://www.sanger.ac.uk/genetics/CGP/Studies/.

ORGANISM(S): Homo sapiens

PROVIDER: GSE17818 | GEO | 2010/01/05

SECONDARY ACCESSION(S): PRJNA123559

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

Somatic Mutation Screen of Clear Cell RCC I

Project description:Systematic somatic mutation screening of 4000 genes in human clear cell renal cell carcinoma. Information on corresponding somatic mutations in each sample can be found at http://www.sanger.ac.uk/genetics/CGP/Studies/. These samples were run at a different facility than VARI - scmmlab.com

2010-01-05 | GSE17816 | GEO

Somatic Mutation Screen of Clear Cell RCC II

Project description:Systematic somatic mutation screening of 4000 genes in human clear cell renal cell carcinoma. Information on corresponding somatic mutations in each sample can be found at http://www.sanger.ac.uk/genetics/CGP/Studies/. Correlating gene expression profiling with mutational status

2010-05-16 | E-GEOD-17818 | biostudies-arrayexpress

Somatic Mutation Screen of Clear Cell RCC

Project description:This SuperSeries is composed of the following subset Series: GSE17816: Somatic Mutation Screen of Clear Cell RCC I GSE17818: Somatic Mutation Screen of Clear Cell RCC II Systematic somatic mutation screening of 4000 genes in human clear cell renal cell carcinoma. Information on corresponding somatic mutations in each sample can be found at http://www.sanger.ac.uk/genetics/CGP/Studies/.

2010-05-16 | E-GEOD-17895 | biostudies-arrayexpress

Somatic Mutation Screen of Clear Cell RCC I

2010-01-04 | E-GEOD-17816 | biostudies-arrayexpress

Somatic Mutation Screen of Clear Cell RCC

Project description: Not available

| S-DIXA-D-1045 | biostudies-other

Somatic Mutation Screen of Clear Cell RCC I

Project description: Not available

| S-DIXA-D-1043 | biostudies-other

Somatic Mutation Screen of Clear Cell RCC II

Project description: Not available

| S-DIXA-D-1044 | biostudies-other

Somatic Mutation Screen of Clear Cell RCC

Project description:This SuperSeries is composed of the SubSeries listed below.

2010-01-05 | GSE17895 | GEO

Lynch Syndrome Can be Diagnosed Just From Somatic Mismatch Repair Mutation

Project description:The objective of the study is the provide proof of high correlation between somatic and germline mismatch repair instability. This correlation is specifically researched in an area where patients have less access to cancer education and genetic testing for various reasons such as lack of insurance and general accessibility. The study concentrates on early diagnosis of Lynch syndrome. Lynch syndrome is usually diagnosed from a blood test resulting in a mutation of one of the mismatch repair genes. Those are MLH1, MSH2, MSH 6, PMS2. A mutation in one of these genes creates a mismatch repair instability,hence higher incidence of cancers in specific organ groups. Amongst these organs are the Uterus, Ovaries, Upper genitourinary system, Pancreas and GI system. The most common endometrial carcinoma which is found in Lynch syndrome is of endometrioid histology. Most patients with known germline mismatch repair instability, have the same somatic mutation. Our study is looking into correlating somatic mutation to germline mutation. By doing so, patients diagnosed with somatic mismatch repair instability will be also diagnosed with lynch syndrome without germline genetic testing. Screening programs will be utilized earlier and preventive procedures offered. Due to less access to educational programs, genetic counseling and testing in underserved areas, patients are sometimes lost to follow up. Our study seeks to prove high correlation between somatic and germline mutations and by doing so, patient will be diagnosed with Lynch syndrome straight after endometrial cancer staging. As a result, increased compliance will be expected and patients will be offered the recommended preventative surgeries and screening protocols.

| 2349042 | ecrin-mdr-crc

Secondary mutation of a somatic BRCA2 mutation

Project description:Secondary mutation of a somatic BRCA2 mutation in an olaparib and carboplatin resistant ovarian tumour

| PRJEB29279 | ENA